Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. EBITDA

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Apr 30, 2024-8-170.01%
Apr 30, 202311-45.68%
Apr 30, 202220+26.80%
Apr 30, 202116-299.97%
Apr 30, 2020-8+172.91%
Apr 30, 2019-3-84.09%
Apr 30, 2018-18-29.93%
Apr 30, 2017-26-52.95%
Apr 30, 2016-55+10.85%
Apr 30, 2015-49+42.45%
Apr 30, 2014-35+27.34%
Apr 30, 2013-27-33.76%
Apr 30, 2012-41

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat